New personalized skin cancer treatment shows success in preventing return of high-risk melanoma - Patients with severe ...

Please provide your email address to receive an email when new articles are posted on . Exposure to metformin lowered the risk for nonmelanoma skin cancer across skin types. However, it was not ...

A personalised mRNA vaccine developed by Moderna and Merck shows lasting benefits for patients with high-risk skin cancer.

Skin cancer is the most common cancer, with almost 2 million cases diagnosed each year across the United States. Skin cancer is the uncontrolled growth of abnormal skin cells. Despite ...

Objective To characterise the risk of subsequent primary non-keratinocyte skin cancers (NKSCs) among adult-onset cancer survivors. Design Data analysis of this population-based cohort study was ...